Innovative Cardiovascular Solutions
Grand Rapids
About Innovative Cardiovascular Solutions
ICS develops novel solutions that offer full capture and protection from embolic material released during left-sided heart procedures. With the first product, the Emblok Embolic Protection System, ICS's goal is to improve patient quality of life and lower overall healthcare costs associated with embolic risks. The company was incorporated in 2012 and is based in Grand Rapids, Michigan.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.4M
- Last round: Debt Financing (Jan 2022)
- Website: emblok.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/innovative-cardiovascular-solutions-65402 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.